Identifying Challenges & Navigating Treatment Landscape for Management of Agitation Associated with Dementia Due to Alzheimer’s Disease
- Home
- Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems
- Identifying Challenges & Navigating Treatment Landscape for Management of Agitation Associated with Dementia Due to Alzheimer’s Disease
Join us for a discussion with Dr. Douglas McLaughlin, as he provides perspective on identifying challenges and navigating the treatment landscape for management of agitation associated with dementia due to Alzheimer’s disease.